Patient-Derived Xenograft (PDX) Models Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Patient-Derived Xenograft (PDX) Models Market size is projected to reach USD 299 million by 2028 from USD 140 million in 2021, at a CAGR of 16% during the forecast period 2022-2028.

Patient-derived xenografts (PDX) are cancer models in which tumor tissue or cells from a patient are transplanted into immunodeficient or humanized mice. The PDX model simulates human tumor biology allowing spontaneous cancer progression and provides the most translational research model for efficacy assessment. Patient-derived xenograft (PDX) mouse models involve the direct delivery of fresh human tumor samples to immunodeficient mice after surgical resection or other medical surgeries.

Market Segments

By Type

• Mice Models
• Rat Models

By Tumor Type

• Gastrointestinal Tumor Models
• Gynecological Tumor Models
• Respiratory Tumor Models
• Urological Tumor Models
• Hematological Tumor Models

By Application

• Preclinical Drug Development
• Biomarker Analysis
• Basic Cancer Research

Key Players

The major players in the market are Crown Bioscience Inc., The Jackson Laboratory, Champions Oncology, Inc., Charles River Laboratories International, Inc., WuXiApptec (Group of Subsidiaries Under WuXiPharmatec), ONCODESIGN, Horizon Discovery Group PLC (Sage Labs, Inc.), Pharmatest Services Ltd., Hera Biolabs, EPO Berlin-Buch GmbH, Xentech, Urolead. 

Scope of the Report

The research study analyzes the global Patient-Derived Xenograft (PDX) Models industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Patient-Derived Xenograft (PDX) Models Market Report

1. What was the Patient-Derived Xenograft (PDX) Models Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Patient-Derived Xenograft (PDX) Models Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Patient-Derived Xenograft (PDX) Models Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.